Novartis AG Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.63 | $1.73 | $1.68 |
| Q2 2024 | 1 | $1.85 | $1.85 | $1.85 |
| Q3 2024 | 3 | $1.93 | $1.95 | $1.94 |
| Q4 2024 | 5 | $1.77 | $1.94 | $1.84 |
| Q1 2025 | 2 | $1.94 | $1.96 | $1.95 |
| Q2 2025 | 1 | $2.13 | $2.23 | $2.17 |
| Q3 2025 | 1 | $2.05 | $2.14 | $2.08 |
| Q4 2025 | 1 | $1.93 | $2.02 | $1.96 |
Novartis AG Earnings Date And Information
Novartis AG last posted its earnings results on Tuesday, October 29th, 2024. The company reported $2.06 earnings per share for the quarter, topping analysts' consensus estimates of $1.94 by $0.12. The company had revenue of 13.17 B for the quarter and had revenue of 46.66 B for the year. Novartis AG has generated $7 earnings per share over the last year ($7.1 diluted earnings per share) and currently has a price-to-earnings ratio of 12.24. Novartis AG has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based on prior year's report dates.
Novartis AG Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/28/2024 | Q3 2024 | $1.58 | $12.79 B | $13.17 B | ||
| 06/28/2024 | Q2 2024 | $1.60 | $12.45 B | $12.51 B | ||
| 03/29/2024 | Q1 2024 | $1.32 | $11.83 B | |||
| 01/31/2024 | Q4 2023 | $1.64 | $4.14 | 2.5 | $11.78 B | |
| 09/30/2023 | Q3 2023 | $0.85 | $12.42 B | $12.09 B | ||
| 06/30/2023 | Q2 2023 | $1.11 | $13.47 B | $13.94 B | ||
| 03/31/2023 | Q1 2023 | $1.09 | $13.21 B | |||
| 02/01/2023 | Q4 2022 | $1.42 | $0.69 | -0.73 | $13.09 B | |
| 09/29/2022 | Q3 2022 | $0.73 | $12.88 B | $12.84 B | ||
| 06/29/2022 | Q2 2022 | $0.77 | $12.88 B | $13.09 B | ||
| 03/30/2022 | Q1 2022 | $1.00 | $12.81 B | |||
| 02/02/2022 | Q4 2021 | $1.44 | $7.29 | 5.85 | $13.52 B | |
| 09/29/2021 | Q3 2021 | $1.23 | $13.06 B | $13.37 B | ||
| 06/29/2021 | Q2 2021 | $1.29 | $12.55 B | $13.29 B | ||
| 03/30/2021 | Q1 2021 | $0.91 | $12.69 B | |||
| 01/26/2021 | Q4 2020 | $1.38 | $0.92 | -0.46 | $13.03 B | |
| 09/29/2020 | Q3 2020 | $0.85 | $12.60 B | $12.54 B | ||
| 06/29/2020 | Q2 2020 | $0.82 | $11.84 B | $11.62 B | ||
| 03/30/2020 | Q1 2020 | $0.96 | $12.71 B | |||
| 01/29/2020 | Q4 2019 | $1.32 | $0.50 | -0.82 | $12.72 B |
Novartis AG Earnings: Frequently Asked Questions
-
When is Novartis AG's earnings date?
Novartis AG has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 29th, 2025 based off last year's report dates.
-
Did Novartis AG beat their earnings estimates last quarter?
In the previous quarter, Novartis AG (:NVS) reported $2.06 earnings per share (EPS) to beat the analysts' consensus estimate of $1.94 by $0.12.
-
How can I listen to Novartis AG's earnings conference call?
The conference call for Novartis AG's latest earnings report can be listened to online.
-
How can I read Novartis AG's conference call transcript?
The conference call transcript for Novartis AG's latest earnings report can be read online.
-
How much revenue does Novartis AG generate each year?
Novartis AG (:NVS) has a recorded annual revenue of $46.66 B.
-
How much profit does Novartis AG generate each year?
Novartis AG (:NVS) has a recorded net income of $46.66 B. Novartis AG has generated $7.15 earnings per share over the last four quarters.
-
What is Novartis AG's price-to-earnings ratio?
Novartis AG (:NVS) has a price-to-earnings ratio of 12.24 and price/earnings-to-growth ratio is 1.31.
